Related Experiment Video
Updated: Jun 24, 2025
06:00
Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection
Published on: January 26, 2024
1.3K
Immunization against dengue virus infection is coercive: A timely call
Iftekhar Ahmed1, Rayhan Ahamed1, Shamsun Nahar1
1Department of Pharmacy, School of Medicine University of Asia Pacific Dhaka Bangladesh.
Health Science Reports
|June 7, 2024
Summary
Developing safe and effective dengue vaccines is crucial for global health. This article focuses on the critical need for accessible dengue immunization, especially in Bangladesh, to combat rising infection rates.
Area of Science:
- Virology
- Epidemiology
- Immunology
Background:
- Dengue virus causes dengue fever, a mosquito-borne illness with a significant global mortality rate.
- Dengue fever incidence is increasing, raising global health concerns.
- Mosquito-borne diseases pose a substantial public health challenge worldwide.
Purpose of the Study:
- To highlight the critical need for developing and disseminating safe and effective dengue vaccines.
- To address the challenges and importance of dengue immunization strategies.
- To emphasize the urgency of vaccination in controlling dengue outbreaks.
Main Methods:
- Review of current dengue vaccine landscape, including Dengvaxia and Qdenga.
- Analysis of clinical study results for the TV005 tetravalent live-attenuated dengue vaccine.
- Focus on the challenges and requirements for vaccine development and distribution.
Main Results:
- Existing dengue vaccines like Dengvaxia have significant drawbacks.
- The Qdenga vaccine awaits FDA approval in the United States.
- The TV005 vaccine demonstrated positive results in a Phase II clinical study in Bangladesh.
Conclusions:
- Effective dengue vaccination is essential to reduce infection and mortality rates.
- Safe and effective vaccine development and equitable dissemination are paramount.
- Addressing the global dengue burden requires urgent advancements in immunization.
